P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847716.29326.a8 |
| _version_ | 1797281746136334336 |
|---|---|
| author | B. E. Wahlin J. Brody T. Phillips R. Costello P. Lugtenburg R. Cordoba L. Wang J. Wu B. Elliott A. Abbas J. Jørgensen |
| author_facet | B. E. Wahlin J. Brody T. Phillips R. Costello P. Lugtenburg R. Cordoba L. Wang J. Wu B. Elliott A. Abbas J. Jørgensen |
| author_sort | B. E. Wahlin |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:53Z |
| format | Article |
| id | doaj.art-5d7cef0b260a42b2a068da0a4b6865dc |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:53Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-5d7cef0b260a42b2a068da0a4b6865dc2024-03-03T03:19:38ZengWileyHemaSphere2572-92412022-06-0161099110010.1097/01.HS9.0000847716.29326.a8202206003-01099P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTB. E. Wahlin0J. Brody1T. Phillips2R. Costello3P. Lugtenburg4R. Cordoba5L. Wang6J. Wu7B. Elliott8A. Abbas9J. Jørgensen101 Karolinska Institutet, Stockholm, Sweden2 Icahn School of Medicine at Mount Sinai, New York3 University of Michigan Comprehensive Cancer Center, Ann Arbor, United States of America4 Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille, France5 Department of Hematology, On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Rotterdam, Netherlands6 Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain7 Genmab, Princeton8 AbbVie, North Chicago, United States of America7 Genmab, Princeton7 Genmab, Princeton9 Aarhus University Hospital, Aarhus, Denmarkhttp://journals.lww.com/10.1097/01.HS9.0000847716.29326.a8 |
| spellingShingle | B. E. Wahlin J. Brody T. Phillips R. Costello P. Lugtenburg R. Cordoba L. Wang J. Wu B. Elliott A. Abbas J. Jørgensen P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT HemaSphere |
| title | P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_full | P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_fullStr | P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_full_unstemmed | P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_short | P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_sort | p1213 subcutaneous epcoritamab with gemox induced high response rates in patients with relapsed refractory diffuse large b cell lymphoma ineligible for autologous stem cell transplant |
| url | http://journals.lww.com/10.1097/01.HS9.0000847716.29326.a8 |
| work_keys_str_mv | AT bewahlin p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT jbrody p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT tphillips p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT rcostello p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT plugtenburg p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT rcordoba p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT lwang p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT jwu p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT belliott p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT aabbas p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant AT jjørgensen p1213subcutaneousepcoritamabwithgemoxinducedhighresponseratesinpatientswithrelapsedrefractorydiffuselargebcelllymphomaineligibleforautologousstemcelltransplant |